Stay updated on BeyoND Study: ND0612 Safety in Advanced PD Clinical Trial
Sign up to get notified when there's something new on the BeyoND Study: ND0612 Safety in Advanced PD Clinical Trial page.

Latest updates to the BeyoND Study: ND0612 Safety in Advanced PD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added; the government funding notice and Revision: v3.4.1 were removed.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a site-wide funding/operational notice and updated the revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.3%

- Check28 days agoChange DetectedAdditions: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Deletions: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page revision label was updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check63 days agoChange DetectedA consolidated Locations section has been added, listing study sites by state (Arizona, Arkansas, California, Colorado, Florida, Illinois, Iowa, Maryland, Michigan, New Jersey, Ohio, Oklahoma, Virginia, Washington) and the previous individual state location subsections have been removed. The HHS Vulnerability Disclosure link was removed and the revision updated from v3.3.2 to v3.3.3.SummaryDifference1%

- Check85 days agoChange Detected- Minor version update: Revision: v3.3.2 replaces v3.3.1; no user-facing changes to the study details, eligibility criteria, or results are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to BeyoND Study: ND0612 Safety in Advanced PD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BeyoND Study: ND0612 Safety in Advanced PD Clinical Trial page.